Search Results

You are looking at 91 - 100 of 1,430 items for :

  • Refine by Access: All x
Clear All
Full access

Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study

Quisette P. Janssen, Jacob L. van Dam, Laura R. Prakash, Deesje Doppenberg, Christopher H. Crane, Casper H.J. van Eijck, Susannah G. Ellsworth, William R. Jarnagin, Eileen M. O’Reilly, Alessandro Paniccia, Marsha Reyngold, Marc G. Besselink, Matthew H.G. Katz, Ching-Wei D. Tzeng, Amer H. Zureikat, Bas Groot Koerkamp, Alice C. Wei, and for the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium

declare itself for patients with elevated tumor markers, thereby improving patient selection for surgery. 4 In the current NCCN Guidelines (Version 2.2021), neoadjuvant chemotherapy may be followed by radiotherapy (RT), without clear specification on

Full access

BPI24-019: Estimation of Impact of Care Gap on Patient Outcome and Health Care Cost Burden Using Real World Data in Early-Stage NSCLC—An Empirical Study for Delay in Surgery

Atharv Sharma, Manu Prasad, Tianyuan Hu, Arunav Saikia, Prabhakar Gaur, Venkata Sai Sumanth Pulluri, and Stuti Jha

Background: Early-stage Non–Small Cell Lung Cancer (eNSCLC) patients often face delays in care, placing additional burden on healthcare system. This study assesses the real-world impact of delay in surgery on healthcare resource utilization in

Full access

Comparison of Treatment Strategies for Patients With Clinical Stage T1–3/N2 Lung Cancer

Ya-Fu Cheng, Wei-Heng Hung, Heng-Chung Chen, Ching-Yuan Cheng, Ching-Hsiung Lin, Sheng-Hao Lin, and Bing-Yen Wang

studies. 6 Although many issues remain unresolved, most contemporary lung cancer studies include surgery in the multimodal treatment of cT1–3N2 disease. This study aimed to identify the optimal therapeutic method and surgical strategy for cT1–3N2 lung

Full access

CGE22-095: CCND1 Amplification in Pancreatic Ductal and Ampullary Adenocarcinoma and Its Impact on Patients’ Survival: A Single Centre Observational Study

Shuchismita Chakraborty and Shibajyoti Ghosh

Full access

Patient Case Studies and Panel Discussion: Lymphoma

angioimmunoblastic T-cell lymphoma (AITL). Figure 1. Patient case study 1: results of further testing. Abbreviations: NGS, next-generation sequencing; RUL, right upper lobe; SUV, standard uptake value; VATS, video-assisted thoracic surgery. Dr. Advani explained that

Full access

New Treatment Guidelines for Penile Cancer

Philippe E. Spiess

faced with this potentially disfiguring and lethal cancer. Treatment Strategies for Primary Penile Tumors Radical surgery (partial or total penectomy with a negative surgical margin) remains the gold standard in managing invasive penile cancer

Full access

Treatment of Non–Small Cell Lung Cancer in the Older Patient

Apar Kishor Ganti, Mollie deShazo, Alva B. Weir III, and Arti Hurria

Fatigue Inventory has helped evaluate the fitness of older patients for cancer surgery. 13 – 15 Clinical trials are ongoing to establish more simplified, time-efficient, and validated instruments to quantify fitness for various forms of therapy. Recent

Full access

Larotrectinib in a Patient With Advanced Pleomorphic Liposarcoma of the Uterus

Anisley Valenciaga, O. Hans Iwenofu, and Gabriel Tinoco

elective robotic hysterectomy and bilateral salpingo-oophorectomy 2 weeks later. Final pathology from the surgery revealed PLU with an anterior and posterior size of 7.0 × 6.0 × 2.1 cm and 8.0 × 6.5 × 4.0 cm, respectively. The histopathology was high

Full access

Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D

John A. Charlson, Emily L. McGinley, Ann B. Nattinger, Joan M. Neuner, and Liliana E. Pezzin

claims. Our inclusion criteria consisted of women aged 65 to 89 years old identified from Medicare claims as having undergone incident breast cancer surgery in 2006 or 2007, based on a validated algorithm 6 applied to nationwide Medicare Parts A and B

Full access

Breast Cancer Risk Reduction and Counseling: Lifestyle, Chemoprevention, and Surgery

Martin C. Mahoney

Qualitative and quantitative approaches to risk assessment are useful for identifying women at increased risk for developing breast cancer for whom genetics consultation, individualized surveillance recommendations, or chemoprevention may be appropriate. A comprehensive medical and family history review can be used to stratify women into categories of breast cancer risk. A quantitative estimate of the probability of developing breast cancer can be determined using risk assessment tools, such as the Gail and Claus models. Women at increased risk for breast cancer may benefit from individualized approaches to breast cancer risk reduction. Prevention strategies for reducing breast cancer risk include lifestyle modifications, chemoprevention, surgical approaches, and pharmacotherapy.